what are topline results

In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks — Photo by

Stop Using Semaglutide? Retatrutide Beats It

Retatrutide outperforms semaglutide in the 80-week Phase 3 trial, cutting A1C 2.1 points more and shedding 23% of body weight versus 15% for semaglutide. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions.